monolaurin has been researched along with Extravascular Hemolysis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Almeida Vaucher, R; de Oliveira, PSB; de Souza Filho, WP; Giongo, JL; Lopes, LQS; Sagrillo, MR; Santos, RCV | 1 |
| Peterson, ML; Schlievert, PM | 1 |
2 other study(ies) available for monolaurin and Extravascular Hemolysis
| Article | Year |
|---|---|
Glycerol monolaurate nanocapsules for biomedical applications: in vitro toxicological studies.
Topics: Animals; Anti-Infective Agents; Biphenyl Compounds; Cell Survival; Chlorocebus aethiops; Comet Assay; Erythrocytes; Hemolysis; Humans; L-Lactate Dehydrogenase; Laurates; Leukocytes, Mononuclear; Lipid Peroxidation; Monoglycerides; Nanocapsules; Picrates; Surface-Active Agents; Vero Cells | 2019 |
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells.
Topics: Animals; Antigens, Bacterial; Bacterial Toxins; Cells, Cultured; Endothelium, Vascular; Erythrocytes; Exotoxins; Hemolysin Proteins; Hemolysis; Humans; Inositol 1,4,5-Trisphosphate; Laurates; Monoglycerides; Rabbits; Shock, Septic; Superantigens; T-Lymphocytes | 2006 |